{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:25:19Z","timestamp":1787970319707,"version":"build-2784847793"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaip.2018.11.041","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T13:46:58Z","timestamp":1544104018000},"page":"1676-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment can be continued for mild cutaneous reactions associated with efavirenz"],"prefix":"10.1016","volume":"7","author":[{"given":"Thuraya","family":"Isaacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald Mduzumile","family":"Ngwanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sipho","family":"Dlamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonny","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rannakoe","family":"Lehloenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.11.041_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0151-9638(05)79559-4","article-title":"Cutaneous drug-reactions to nevirapine: study of risk factors in 101 HIV-infected patients","volume":"132","author":"Pitche","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.11.041_bib2","doi-asserted-by":"crossref","first-page":"e0171596","DOI":"10.1371\/journal.pone.0171596","article-title":"Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2018.11.041_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bcp.12590","article-title":"Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa","volume":"80","author":"Sinxadi","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2018.11.041_bib4","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/jac\/dkt287","article-title":"Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases","volume":"68","author":"Isaacs","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2018.11.041_bib5","first-page":"815","article-title":"Cutaneous adverse drug reactions caused by FDCAs\u2014we need to characterise and manage them urgently","volume":"103","author":"Lehloenya","year":"2013","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.jaip.2018.11.041_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2018.11.041_bib7","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. Published July 14, 2010. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_4.03.xlsx. Accessed December 17, 2018."},{"key":"10.1016\/j.jaip.2018.11.041_bib8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/QAD.0000000000001084","article-title":"Identification of a novel and severe pattern of efavirenz drug-induced liver injury in South Africa","volume":"30","author":"Sonderup","year":"2016","journal-title":"AIDS"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818307700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818307700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:19:13Z","timestamp":1761974353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818307700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213219818307700"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.11.041","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment can be continued for mild cutaneous reactions associated with efavirenz","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}